Fresenius says tighter EU rules could trigger antibiotic shortage
Date
05 June 2019
In the article, Ludwig Burger refers to The Foundation’s whitepaper: “Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role for pharmaceutical companies” and points to the emerging crisis in the global anti-infectives market, with piperacillin particularly exposed, as fragile drug supply chains are relying on just a few big suppliers.
The Foundation’s Executive Director Jayasree Iyer spoke to Ludwig Burger about the issue: “It is important to have high standards and companies around the world need to keep investing in their plants. But the risks are clear especially in a market where a lot of manufacturers are disincentivised to stay on board and there’s more and more dependency on fewer manufacturers.”